[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global CRISPR/Cas9 Market Growth (Status and Outlook) 2022-2028

January 2022 | 113 pages | ID: G33FB6E3D30EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of CRISPR/Cas9 will have significant change from previous year. According to our (LP Information) latest study, the global CRISPR/Cas9 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global CRISPR/Cas9 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States CRISPR/Cas9 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global CRISPR/Cas9 market, reaching US$ million by the year 2028. As for the Europe CRISPR/Cas9 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main CRISPR/Cas9 players cover Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR/Cas9 market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
  • Genome Editing
  • Genetic Engineering
  • gRNA Database/Gene Librar
  • CRISPR Plasmid
  • Human Stem Cells
  • Genetically Modified Organisms/Crops
  • Cell Line Engineering
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic Institutes
  • Research and Development Institutes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
  • Caribou Biosciences
  • Integrated DNA Technologies(IDT)
  • CRISPR Therapeutics
  • Merck
  • Mirus Bio
  • Editas Medicine
  • Takara Bio
  • Thermo Fisher Scientific
  • Horizon Discovery Group
  • Intellia Therapeutics
  • Agilent Technologies
  • Cellecta
  • GenScript
  • GeneCopoeia
  • Synthego
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global CRISPR/Cas9 Market Size 2017-2028
  2.1.2 CRISPR/Cas9 Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CRISPR/Cas9 Segment by Type
  2.2.1 Genome Editing
  2.2.2 Genetic Engineering
  2.2.3 gRNA Database/Gene Librar
  2.2.4 CRISPR Plasmid
  2.2.5 Human Stem Cells
  2.2.6 Genetically Modified Organisms/Crops
  2.2.7 Cell Line Engineering
2.3 CRISPR/Cas9 Market Size by Type
  2.3.1 CRISPR/Cas9 Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
2.4 CRISPR/Cas9 Segment by Application
  2.4.1 Biotechnology Companies
  2.4.2 Pharmaceutical Companies
  2.4.3 Academic Institutes
  2.4.4 Research and Development Institutes
2.5 CRISPR/Cas9 Market Size by Application
  2.5.1 CRISPR/Cas9 Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global CRISPR/Cas9 Market Size Market Share by Application (2017-2022)

3 CRISPR/CAS9 MARKET SIZE BY PLAYER

3.1 CRISPR/Cas9 Market Size Market Share by Players
  3.1.1 Global CRISPR/Cas9 Revenue by Players (2020-2022)
  3.1.2 Global CRISPR/Cas9 Revenue Market Share by Players (2020-2022)
3.2 Global CRISPR/Cas9 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CRISPR/CAS9 BY REGIONS

4.1 CRISPR/Cas9 Market Size by Regions (2017-2022)
4.2 Americas CRISPR/Cas9 Market Size Growth (2017-2022)
4.3 APAC CRISPR/Cas9 Market Size Growth (2017-2022)
4.4 Europe CRISPR/Cas9 Market Size Growth (2017-2022)
4.5 Middle East & Africa CRISPR/Cas9 Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas CRISPR/Cas9 Market Size by Country (2017-2022)
5.2 Americas CRISPR/Cas9 Market Size by Type (2017-2022)
5.3 Americas CRISPR/Cas9 Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC CRISPR/Cas9 Market Size by Region (2017-2022)
6.2 APAC CRISPR/Cas9 Market Size by Type (2017-2022)
6.3 APAC CRISPR/Cas9 Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe CRISPR/Cas9 by Country (2017-2022)
7.2 Europe CRISPR/Cas9 Market Size by Type (2017-2022)
7.3 Europe CRISPR/Cas9 Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa CRISPR/Cas9 by Region (2017-2022)
8.2 Middle East & Africa CRISPR/Cas9 Market Size by Type (2017-2022)
8.3 Middle East & Africa CRISPR/Cas9 Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CRISPR/CAS9 MARKET FORECAST

10.1 Global CRISPR/Cas9 Forecast by Regions (2023-2028)
  10.1.1 Global CRISPR/Cas9 Forecast by Regions (2023-2028)
  10.1.2 Americas CRISPR/Cas9 Forecast
  10.1.3 APAC CRISPR/Cas9 Forecast
  10.1.4 Europe CRISPR/Cas9 Forecast
  10.1.5 Middle East & Africa CRISPR/Cas9 Forecast
10.2 Americas CRISPR/Cas9 Forecast by Country (2023-2028)
  10.2.1 United States CRISPR/Cas9 Market Forecast
  10.2.2 Canada CRISPR/Cas9 Market Forecast
  10.2.3 Mexico CRISPR/Cas9 Market Forecast
  10.2.4 Brazil CRISPR/Cas9 Market Forecast
10.3 APAC CRISPR/Cas9 Forecast by Region (2023-2028)
  10.3.1 China CRISPR/Cas9 Market Forecast
  10.3.2 Japan CRISPR/Cas9 Market Forecast
  10.3.3 Korea CRISPR/Cas9 Market Forecast
  10.3.4 Southeast Asia CRISPR/Cas9 Market Forecast
  10.3.5 India CRISPR/Cas9 Market Forecast
  10.3.6 Australia CRISPR/Cas9 Market Forecast
10.4 Europe CRISPR/Cas9 Forecast by Country (2023-2028)
  10.4.1 Germany CRISPR/Cas9 Market Forecast
  10.4.2 France CRISPR/Cas9 Market Forecast
  10.4.3 UK CRISPR/Cas9 Market Forecast
  10.4.4 Italy CRISPR/Cas9 Market Forecast
  10.4.5 Russia CRISPR/Cas9 Market Forecast
10.5 Middle East & Africa CRISPR/Cas9 Forecast by Region (2023-2028)
  10.5.1 Egypt CRISPR/Cas9 Market Forecast
  10.5.2 South Africa CRISPR/Cas9 Market Forecast
  10.5.3 Israel CRISPR/Cas9 Market Forecast
  10.5.4 Turkey CRISPR/Cas9 Market Forecast
  10.5.5 GCC Countries CRISPR/Cas9 Market Forecast
10.6 Global CRISPR/Cas9 Forecast by Type (2023-2028)
10.7 Global CRISPR/Cas9 Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Caribou Biosciences
  11.1.1 Caribou Biosciences Company Information
  11.1.2 Caribou Biosciences CRISPR/Cas9 Product Offered
  11.1.3 Caribou Biosciences CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Caribou Biosciences Main Business Overview
  11.1.5 Caribou Biosciences Latest Developments
11.2 Integrated DNA Technologies(IDT)
  11.2.1 Integrated DNA Technologies(IDT) Company Information
  11.2.2 Integrated DNA Technologies(IDT) CRISPR/Cas9 Product Offered
  11.2.3 Integrated DNA Technologies(IDT) CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Integrated DNA Technologies(IDT) Main Business Overview
  11.2.5 Integrated DNA Technologies(IDT) Latest Developments
11.3 CRISPR Therapeutics
  11.3.1 CRISPR Therapeutics Company Information
  11.3.2 CRISPR Therapeutics CRISPR/Cas9 Product Offered
  11.3.3 CRISPR Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 CRISPR Therapeutics Main Business Overview
  11.3.5 CRISPR Therapeutics Latest Developments
11.4 Merck
  11.4.1 Merck Company Information
  11.4.2 Merck CRISPR/Cas9 Product Offered
  11.4.3 Merck CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 Merck Main Business Overview
  11.4.5 Merck Latest Developments
11.5 Mirus Bio
  11.5.1 Mirus Bio Company Information
  11.5.2 Mirus Bio CRISPR/Cas9 Product Offered
  11.5.3 Mirus Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Mirus Bio Main Business Overview
  11.5.5 Mirus Bio Latest Developments
11.6 Editas Medicine
  11.6.1 Editas Medicine Company Information
  11.6.2 Editas Medicine CRISPR/Cas9 Product Offered
  11.6.3 Editas Medicine CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 Editas Medicine Main Business Overview
  11.6.5 Editas Medicine Latest Developments
11.7 Takara Bio
  11.7.1 Takara Bio Company Information
  11.7.2 Takara Bio CRISPR/Cas9 Product Offered
  11.7.3 Takara Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 Takara Bio Main Business Overview
  11.7.5 Takara Bio Latest Developments
11.8 Thermo Fisher Scientific
  11.8.1 Thermo Fisher Scientific Company Information
  11.8.2 Thermo Fisher Scientific CRISPR/Cas9 Product Offered
  11.8.3 Thermo Fisher Scientific CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 Thermo Fisher Scientific Main Business Overview
  11.8.5 Thermo Fisher Scientific Latest Developments
11.9 Horizon Discovery Group
  11.9.1 Horizon Discovery Group Company Information
  11.9.2 Horizon Discovery Group CRISPR/Cas9 Product Offered
  11.9.3 Horizon Discovery Group CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.9.4 Horizon Discovery Group Main Business Overview
  11.9.5 Horizon Discovery Group Latest Developments
11.10 Intellia Therapeutics
  11.10.1 Intellia Therapeutics Company Information
  11.10.2 Intellia Therapeutics CRISPR/Cas9 Product Offered
  11.10.3 Intellia Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.10.4 Intellia Therapeutics Main Business Overview
  11.10.5 Intellia Therapeutics Latest Developments
11.11 Agilent Technologies
  11.11.1 Agilent Technologies Company Information
  11.11.2 Agilent Technologies CRISPR/Cas9 Product Offered
  11.11.3 Agilent Technologies CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.11.4 Agilent Technologies Main Business Overview
  11.11.5 Agilent Technologies Latest Developments
11.12 Cellecta
  11.12.1 Cellecta Company Information
  11.12.2 Cellecta CRISPR/Cas9 Product Offered
  11.12.3 Cellecta CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.12.4 Cellecta Main Business Overview
  11.12.5 Cellecta Latest Developments
11.13 GenScript
  11.13.1 GenScript Company Information
  11.13.2 GenScript CRISPR/Cas9 Product Offered
  11.13.3 GenScript CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.13.4 GenScript Main Business Overview
  11.13.5 GenScript Latest Developments
11.14 GeneCopoeia
  11.14.1 GeneCopoeia Company Information
  11.14.2 GeneCopoeia CRISPR/Cas9 Product Offered
  11.14.3 GeneCopoeia CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.14.4 GeneCopoeia Main Business Overview
  11.14.5 GeneCopoeia Latest Developments
11.15 Synthego
  11.15.1 Synthego Company Information
  11.15.2 Synthego CRISPR/Cas9 Product Offered
  11.15.3 Synthego CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
  11.15.4 Synthego Main Business Overview
  11.15.5 Synthego Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. CRISPR/Cas9 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Genome Editing
Table 3. Major Players of Genetic Engineering
Table 4. Major Players of gRNA Database/Gene Librar
Table 5. Major Players of CRISPR Plasmid
Table 6. Major Players of Human Stem Cells
Table 7. Major Players of Genetically Modified Organisms/Crops
Table 8. Major Players of Cell Line Engineering
Table 9. CRISPR/Cas9 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 12. CRISPR/Cas9 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 15. Global CRISPR/Cas9 Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global CRISPR/Cas9 Revenue Market Share by Player (2020-2022)
Table 17. CRISPR/Cas9 Key Players Head office and Products Offered
Table 18. CRISPR/Cas9 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global CRISPR/Cas9 Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global CRISPR/Cas9 Market Size Market Share by Regions (2017-2022)
Table 23. Americas CRISPR/Cas9 Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas CRISPR/Cas9 Market Size Market Share by Country (2017-2022)
Table 25. Americas CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 27. Americas CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 29. APAC CRISPR/Cas9 Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC CRISPR/Cas9 Market Size Market Share by Region (2017-2022)
Table 31. APAC CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 33. APAC CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 35. Europe CRISPR/Cas9 Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe CRISPR/Cas9 Market Size Market Share by Country (2017-2022)
Table 37. Europe CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 39. Europe CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa CRISPR/Cas9 Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of CRISPR/Cas9
Table 48. Key Market Challenges & Risks of CRISPR/Cas9
Table 49. Key Industry Trends of CRISPR/Cas9
Table 50. Global CRISPR/Cas9 Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global CRISPR/Cas9 Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global CRISPR/Cas9 Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global CRISPR/Cas9 Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global CRISPR/Cas9 Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global CRISPR/Cas9 Market Size Market Share Forecast by Application (2023-2028)
Table 56. Caribou Biosciences Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 57. Caribou Biosciences CRISPR/Cas9 Product Offered
Table 58. Caribou Biosciences CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Caribou Biosciences Main Business
Table 60. Caribou Biosciences Latest Developments
Table 61. Integrated DNA Technologies(IDT) Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 62. Integrated DNA Technologies(IDT) CRISPR/Cas9 Product Offered
Table 63. Integrated DNA Technologies(IDT) Main Business
Table 64. Integrated DNA Technologies(IDT) CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Integrated DNA Technologies(IDT) Latest Developments
Table 66. CRISPR Therapeutics Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 67. CRISPR Therapeutics CRISPR/Cas9 Product Offered
Table 68. CRISPR Therapeutics Main Business
Table 69. CRISPR Therapeutics CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. CRISPR Therapeutics Latest Developments
Table 71. Merck Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 72. Merck CRISPR/Cas9 Product Offered
Table 73. Merck Main Business
Table 74. Merck CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Merck Latest Developments
Table 76. Mirus Bio Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 77. Mirus Bio CRISPR/Cas9 Product Offered
Table 78. Mirus Bio Main Business
Table 79. Mirus Bio CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Mirus Bio Latest Developments
Table 81. Editas Medicine Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 82. Editas Medicine CRISPR/Cas9 Product Offered
Table 83. Editas Medicine Main Business
Table 84. Editas Medicine CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Editas Medicine Latest Developments
Table 86. Takara Bio Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 87. Takara Bio CRISPR/Cas9 Product Offered
Table 88. Takara Bio Main Business
Table 89. Takara Bio CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Takara Bio Latest Developments
Table 91. Thermo Fisher Scientific Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 92. Thermo Fisher Scientific CRISPR/Cas9 Product Offered
Table 93. Thermo Fisher Scientific Main Business
Table 94. Thermo Fisher Scientific CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Thermo Fisher Scientific Latest Developments
Table 96. Horizon Discovery Group Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 97. Horizon Discovery Group CRISPR/Cas9 Product Offered
Table 98. Horizon Discovery Group Main Business
Table 99. Horizon Discovery Group CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Horizon Discovery Group Latest Developments
Table 101. Intellia Therapeutics Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 102. Intellia Therapeutics CRISPR/Cas9 Product Offered
Table 103. Intellia Therapeutics Main Business
Table 104. Intellia Therapeutics CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Intellia Therapeutics Latest Developments
Table 106. Agilent Technologies Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 107. Agilent Technologies CRISPR/Cas9 Product Offered
Table 108. Agilent Technologies CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Agilent Technologies Main Business
Table 110. Agilent Technologies Latest Developments
Table 111. Cellecta Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 112. Cellecta CRISPR/Cas9 Product Offered
Table 113. Cellecta Main Business
Table 114. Cellecta CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Cellecta Latest Developments
Table 116. GenScript Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 117. GenScript CRISPR/Cas9 Product Offered
Table 118. GenScript Main Business
Table 119. GenScript CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. GenScript Latest Developments
Table 121. GeneCopoeia Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 122. GeneCopoeia CRISPR/Cas9 Product Offered
Table 123. GeneCopoeia Main Business
Table 124. GeneCopoeia CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. GeneCopoeia Latest Developments
Table 126. Synthego Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 127. Synthego CRISPR/Cas9 Product Offered
Table 128. Synthego Main Business
Table 129. Synthego CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Synthego Latest Developments

LIST OF FIGURES

Figure 1. CRISPR/Cas9 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CRISPR/Cas9 Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CRISPR/Cas9 Market Size Market Share by Type in 2021
Figure 7. CRISPR/Cas9 in Biotechnology Companies
Figure 8. Global CRISPR/Cas9 Market: Biotechnology Companies (2017-2022) & ($ Millions)
Figure 9. CRISPR/Cas9 in Pharmaceutical Companies
Figure 10. Global CRISPR/Cas9 Market: Pharmaceutical Companies (2017-2022) & ($ Millions)
Figure 11. CRISPR/Cas9 in Academic Institutes
Figure 12. Global CRISPR/Cas9 Market: Academic Institutes (2017-2022) & ($ Millions)
Figure 13. CRISPR/Cas9 in Research and Development Institutes
Figure 14. Global CRISPR/Cas9 Market: Research and Development Institutes (2017-2022) & ($ Millions)
Figure 15. Global CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 16. Global CRISPR/Cas9 Revenue Market Share by Player in 2021
Figure 17. Global CRISPR/Cas9 Market Size Market Share by Regions (2017-2022)
Figure 18. Americas CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 19. APAC CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 20. Europe CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 22. Americas CRISPR/Cas9 Value Market Share by Country in 2021
Figure 23. Americas CRISPR/Cas9 Consumption Market Share by Type in 2021
Figure 24. Americas CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 25. United States CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC CRISPR/Cas9 Market Size Market Share by Region in 2021
Figure 30. APAC CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 31. China CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 35. India CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe CRISPR/Cas9 Market Size Market Share by Country in 2021
Figure 38. Europe CRISPR/Cas9 Market Size Market Share by Type in 2021
Figure 39. Europe CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 40. Germany CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 41. France CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 48. Egypt CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 54. APAC CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 55. Europe CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 57. United States CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 58. Canada CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 59. Mexico CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 60. Brazil CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 61. China CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 62. Japan CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 63. Korea CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 65. India CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 66. Australia CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 67. Germany CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 68. France CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 69. UK CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 70. Italy CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 71. Russia CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 72. Spain CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 73. Egypt CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 74. South Africa CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 75. Israel CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 76. Turkey CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries CRISPR/Cas9 Market Size 2023-2028 ($ Millions)


More Publications